184 related articles for article (PubMed ID: 25077623)
21. 6th Japan Bioanalysis Forum Symposium: challenge of regulated bioanalysis.
Igarashi H
Bioanalysis; 2015; 7(14):1711-5. PubMed ID: 26270778
[TBL] [Abstract][Full Text] [Related]
22. Scientific or regulated validation: a tiered approach? Meeting report from a joint EBF/DVDMDG workshop.
Timmerman P; Lowes S; McDougall S; Colligon I; Miksic J; Chowdhury S; White S; Aubry AF; Jenkins R; Kemper C
Bioanalysis; 2015; 7(14):1703-10. PubMed ID: 26270777
[TBL] [Abstract][Full Text] [Related]
23. Feedback from the Sixth European Bioanalysis Forum Young Scientist Symposium.
Delahaye L; Calogero S; Gunning C; Hetzel T; McDonald T; Munday C; Protti M; Salger M; Schlicksupp L; Sleumer B; Walker C; Williams A; Wördenweber R; Timmerman P
Bioanalysis; 2021 May; 13(9):669-674. PubMed ID: 33856267
[TBL] [Abstract][Full Text] [Related]
24. Feedback from the European Bioanalysis Forum Workshop: taking tiered approach to the next level.
Timmerman P; White S; Knutsson M; Kall MA; Fjording MS; Smeraglia J; McDougall S
Bioanalysis; 2014; 6(19):2593-8. PubMed ID: 25411702
[No Abstract] [Full Text] [Related]
25. Best practices in performing flow cytometry in a regulated environment: feedback from experience within the European Bioanalysis Forum.
der Strate BV; Longdin R; Geerlings M; Bachmayer N; Cavallin M; Litwin V; Patel M; Passe-Coutrin W; Schoelch C; Companjen A; Fjording MS
Bioanalysis; 2017 Aug; 9(16):1253-1264. PubMed ID: 28766359
[TBL] [Abstract][Full Text] [Related]
26. Update to the European Bioanalysis Forum recommendation on biomarkers assays; bringing context of use into practice.
Goodman J; Cowan KJ; Golob M; Karlsson L; Kunz U; Nelson R; Ulrichts H; Stevenson L; Terry L; Timmerman P
Bioanalysis; 2020 Oct; 12(20):1427-1437. PubMed ID: 33025797
[TBL] [Abstract][Full Text] [Related]
27. Giving consideration to scientific validation in Japanese drug application by Japan Bioanalysis Forum discussion group.
Koseki N; Ashizawa H; Ishii T; Uchimura T; Ono K; Kuriyama S; Toda A; Soejima K; Nakai N; Nishimura N; Mayumi T; Yasuda Y; Yamakawa T; Niwa M
Bioanalysis; 2017 Jul; 9(13):963-968. PubMed ID: 28708436
[No Abstract] [Full Text] [Related]
28. Update of the EBF recommendation for the use of DBS in regulated bioanalysis integrating the conclusions from the EBF DBS-microsampling consortium.
Timmerman P; White S; Cobb Z; de Vries R; Thomas E; van Baar B;
Bioanalysis; 2013 Sep; 5(17):2129-36. PubMed ID: 23829466
[TBL] [Abstract][Full Text] [Related]
29. EBF recommendation for stability testing of anti-drug antibodies; lessons learned from anti-vaccine antibody stability studies.
Pihl S; Michaut L; Hendriks J; Loebbert R; Ryding J; Nemansky M; Vermet L; Companjen A
Bioanalysis; 2014 May; 6(10):1409-13. PubMed ID: 24958124
[TBL] [Abstract][Full Text] [Related]
30. 2020 White Paper on Recent Issues in Bioanalysis: BAV Guidance, CLSI H62, Biotherapeutics Stability, Parallelism Testing, CyTOF and Regulatory Feedback (
Spitz S; Zhang Y; Fischer S; McGuire K; Sommer U; Amaravadi L; Bandukwala A; Eck S; Garofolo F; Islam R; Jordan G; King L; Saito Y; Sumner G; Terry L; Vitaliti A; Wang YM; Grimaldi C; Joyce A; Palmer R; Andisik M; Araya M; Azadeh M; Baltrukonis D; Elliott R; Haidar S; Kumar S; Mayer A; Neff F; Palackal N; Peng K; Abhari MR; Satterwhite C; Savoie N; Soo C; Vinter S; Welink J; Yan W; Maher K; Lanham D; Bertholet S; Dakappagari N; Gonneau C; Green C; Junker F; Kar S; Patti-Diaz L; Sarikonda S; McCausland M; Teixeira PC; Decman V; Estevam J; Hedrick M; Robert AH; Hopkins G; Nuti S; Tangri S; Wnek R; Dandamudi S; Dasgupta A; Edmison A; Faustino P; McGuinness M; Lima Santos GM; Mirza T; Shakleya D; Stojdl S; Tampal N; Zhang J; Cherry E; Cludts I; Exley A; Ishii-Watabe A; Kirshner S; Pedras-Vasconcelos J; Shen M; Siggers R; Solstad T; Verthelyi D; Yan H; Zhang L
Bioanalysis; 2021 Mar; 13(5):295-361. PubMed ID: 33511867
[TBL] [Abstract][Full Text] [Related]
31. Applying context of use to quantitative polymerase chain reaction method validation and analysis: a recommendation from the European Bioanalysis Forum.
Laurén A; Braun M; Byrne P; Cazzin C; Colletti K; Cox C; Dietz L; Emrich T; Geddes K; Herr K; Iles T; Rogue A; Verlinden Y; Timmerman P
Bioanalysis; 2021 Dec; 13(23):1723-1729. PubMed ID: 34708666
[TBL] [Abstract][Full Text] [Related]
32. Regulated drug bioanalysis for human pharmacokinetic studies and therapeutic drug management.
Huang Y; Shi R; Gee W; Bonderud R
Bioanalysis; 2012 Aug; 4(15):1919-31. PubMed ID: 22943622
[TBL] [Abstract][Full Text] [Related]
33. Improving data integrity in regulated bioanalysis: proposal for a generic data transfer process for LC-MS from the European Bioanalysis Forum.
Arfvidsson C; Bedaf DV; Globig S; Knutsson M; Lewis M; McDougall S; Michi M; Timmerman P
Bioanalysis; 2020 Jul; 12(14):1033-1038. PubMed ID: 32706625
[TBL] [Abstract][Full Text] [Related]
34. 2019 White Paper on Recent Issues in Bioanalysis: FDA Immunogenicity Guidance, Gene Therapy, Critical Reagents, Biomarkers and Flow Cytometry Validation (Part 3 - Recommendations on 2019 FDA Immunogenicity Guidance, Gene Therapy Bioanalytical Challenges, Strategies for Critical Reagent Management, Biomarker Assay Validation, Flow Cytometry Validation & CLSI H62).
Piccoli S; Mehta D; Vitaliti A; Allinson J; Amur S; Eck S; Green C; Hedrick M; Hopper S; Ji A; Joyce A; Litwin V; Maher K; Mathews J; Peng K; Safavi A; Wang YM; Zhang Y; Amaravadi L; Palackal N; Thankamony S; Beaver C; Bame E; Emrich T; Grimaldi C; Haulenbeek J; Joyce A; Kakkanaiah V; Lanham D; Maher K; Mayer A; Trampont PC; Vermet L; Dakappagari N; Fleener C; Garofolo F; Rogers C; Tangri S; Xu Y; Liang M; Rajadhyaksha M; Richards S; Schweighardt B; Purushothama S; Baltrukonis D; Brumm J; Cherry E; Delcarpini J; Gleason C; Kirshner S; Kubiak R; Pan L; Partridge M; Pedras-Vasconcelos J; Qu Q; Skibeli V; Saunders TS; Staack RF; Stubenrauch K; Torri A; Verthelyi D; Yan H; Gorovits B; Palmer R; Milton M; Long B; Corsaro B; Farrokhi V; Fiscella M; Henderson N; Jawa V; McNally J; Murphy R; Waldner H; Yang TY
Bioanalysis; 2019 Dec; 11(24):2207-2244. PubMed ID: 31820675
[TBL] [Abstract][Full Text] [Related]
35. The quest for assay robustness across the life cycle of a bioanalytical method.
White S; Dunn J; Summerfield S
Bioanalysis; 2015; 7(7):815-24. PubMed ID: 25932516
[TBL] [Abstract][Full Text] [Related]
36. Conference Report: 4th Japan Bioanalysis Forum Symposium: Japanese guidelines on bioanalytical method validation and latest discussion within the Japanese bioanalyst community.
Nakayama A; Nakamura T
Bioanalysis; 2014 Apr; 6(7):915-7. PubMed ID: 24806901
[TBL] [Abstract][Full Text] [Related]
37. How the bioanalytical scientist plays a key role in interdisciplinary project teams in the development of biotherapeutics - a reflection of the European Bioanalysis Forum.
Dudal S; Staack RF; Stoellner D; Fjording MS; Vieser E; Pascual MH; Brudny-Kloeppel M; Golob M
Bioanalysis; 2014 May; 6(10):1339-48. PubMed ID: 24958118
[TBL] [Abstract][Full Text] [Related]
38. IS addition in bioanalysis of DBS: results from the EBF DBS-microsampling consortium.
van Baar BL; Verhaeghe T; Heudi O; Rohde M; Wood S; Wieling J; de Vries R; White S; Cobb Z; Timmerman P
Bioanalysis; 2013 Sep; 5(17):2137-45. PubMed ID: 23829464
[TBL] [Abstract][Full Text] [Related]
39. Feedback from the European Bioanalysis Forum: focus workshop on current analysis of immunogenicity: best practices and regulatory hurdles.
Goodman J; Cowen S; Devanarayan V; Egging D; Emrich T; Golob M; Kramer D; McNally J; Munday J; Nelson R; Pedras-Vasconcelos JA; Piironen T; Sickert D; Skibeli V; Fjording MS; Timmerman P
Bioanalysis; 2018 Feb; 10(4):197-204. PubMed ID: 29345496
[TBL] [Abstract][Full Text] [Related]
40. European Bioanalysis Forum recommendation on singlicate analysis for ligand binding assays: time for a new mindset.
Barfield M; Goodman J; Hood J; Timmerman P
Bioanalysis; 2020 Mar; 12(5):273-284. PubMed ID: 31975612
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
